Clasado has revealed the focus of the latest study from Nottingham Trent University in collaboration with Clasado, underlining the potential role of prebiotics in supporting sport and athletic health.
At the upcoming European College of Sports Science Conference, held 30th August to 2nd September in Seville, Spain, the findings of the study will be presented to delegates from the athletic health field by its Principal Investigator Dr Neil Williams, Senior Lecturer at Nottingham Trent University.
Dr Williams’ lecture will take place on the second day of the event, 31st August at 11:30CET, as part of the Physiology & Nutrition session. This will be followed by an oral presentation from Connor Parker of Nottingham Trent University, taking place on 2nd September at 8:00CET.
The study utilised a randomised controlled methodology, to measure the effects of a 24-week prebiotic intervention on markers of immunity and upper respiratory symptoms (URS) and gastrointestinal symptoms (GIS) in top-flight rugby union players. The conclusion of the study shows promising effects in the measured outcomes following a consistent course of prebiotics.
Dr Neil Williams commented: “We are delighted to showcase the findings from this latest study as we continue to uncover the links between the gut microbiome and athletic health. In particular, the study focuses on markers of immunity, upper respiratory and gastrointestinal symptoms, which are of particular interest in the sport health community.
“There is a great deal of insight to be gained from the study, which further points to the importance of the gut microbiome in supporting athletic health. The study showed that twenty-four weeks of prebiotic supplementation reduced the duration of upper respiratory symptoms, as well as the incidence and severity of gastrointestinal symptoms. Crucially, the number of GI symptom-free weeks was higher with Bimuno GOS, pointing towards greater availability for athletic training and competition.”
Further solidifying the potential use of prebiotics in formulations that target athletic health, the study adds to the portfolio of science behind Bimuno® GOS, which includes over 100 scientific publications and more than 20 clinical trials.
Dr Lucien Harthoorn, R&D Director at Clasado Biosciences, adds: “We are excited to share the findings from the collaborative study of Nottingham Trent University. Using Bimuno GOS as a base, we have been able to further explore the potential of prebiotics in a sports environment.
“The findings suggest that Bimuno GOS has the potential to modulate immune function and reduce the duration of URS and the incidence and severity of GIS, which may improve an athlete’s ability to train and compete. As we look ahead to what the future of sport health and nutrition looks like, it’s clear that there is a prominent and distinct role for prebiotics and gut microbiome modulation. We look forward to the research study team from Nottingham Trent University sharing the data and insight from the study at the European College of Sport Science conference and the influence this can have on developing science-backed prebiotic solutions within the sports market.”
To learn more about Clasado Biosciences and the scientific portfolio behind Bimuno GOS, please visit www.clasado.com
